Abstract:SDF‐1 is a ligand that plays a critical role in cancer metastases and is secreted in specialized somatic cells in the body. Its chemoattractant properties attract and induce migration of tumor cells located in other tissues in the body to the site in which SDF‐1 is secreted. This attraction and migration of tumor cells allows a new tumor to form at secondary locations within the body. Although the understanding of the function of SDF‐1 being secreted in certain regions of the body is not clear, we seek to understand the binding patterns of this ligand with its chemokine receptors CXCR4 and ACKR3 (also called CXCR7). Chemokine receptors are a subclass of G‐protein coupled receptors, which are multi‐pass transmembrane proteins with 7 TM domains. GPCR activation initiates signaling cascades within the targeted cell. Understanding which signaling pathway is favored in CXCR4 and ACKR3 can help us understand the function of SDF‐1 and the mechanism of secondary tumor formation and development. ACKR3 is considered an atypical receptor as it has been experimentally shown to not couple to Gi/o protein in many cells whereas CXCR4 can couple to either Gi/oprotein or β‐arrestin. ACKR3 strongly binds to SDF‐1 and can control the local levels of SDF‐1 available for binding to CXCR4. Both receptors can couple to β‐arrestins, which are proteins responsible for receptor internalization and potential G‐protein‐independent signaling. To understand the interplay between these two receptors in the context of their interactions with SDF‐1, Gi protein, and β‐arrestin, we have successfully generated structural models of these two receptors in apo form, as heterodimers (bound to only SDF‐1, only Gi protein, or only β‐arrestin), and as heterotrimers (bound to both SDF‐1 and Gi protein, or both SDF‐1 and β‐arrestin). These structural models have been relaxed in their physiological environment using a series of molecular dynamics (MD) simulations. Binding free energy analysis of the heterodimers is beginning to shed light on the signaling differences between the two receptors, what identifies ACKR3 as an atypical receptor, and how it sequesters excess SDF‐1 to modulate CXCR4 signaling.

Attachment of C-terminus of SDF-1 Enhances the Biological Activity of Its N-terminal Peptide.

Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal α-helix of SDF-1α plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity

Loss of C-terminal Alpha-Helix Decreased SDF-1alpha-mediated Signaling and Chemotaxis Without Influencing CXCR4 Internalization.

Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues.

E-Selectin Mediated Adhesion and Migration of Endothelial Colony Forming Cells is Enhanced by SDF-1α/CXCR4

The Role of Positively Charged Residues in CXCR4 Recognition Probed with Synthetic Peptides

SDF-1/54-DCN: a novel recombinant chimera with dual inhibitory effects on proliferation and chemotaxis of tumor cells.

The Role of SDF‐1 in Signaling Differences Between CXCR4 and Atypical ACKR3 Chemokine Receptors

Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design.

The Structure and Function of SDF-1 and Its Receptor CXCR4

Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.

Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.

Structural Basis of the Interactions Between Cxcr4 and Cxcl12/Sdf-1 Revealed by Theoretical Approaches

The Chemokine SDF-1 Α Suppresses Fibronectin-mediated in Vitro Lymphocytes Adhesion

Role Of Cxcr4 Internalization In The Anti-Hiv Activity Of Stromal Cell-Derived Factor-1 Alpha Probed By A Novel Synthetically And Modularly Modified-Chemokine Analog

Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1α Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans*

SDF‐1α/CXCR4 signaling promotes capillary tube formation of human retinal vascular endothelial cells by activating ERK1/2 and PI3K pathways in vitro

The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus

SDF-1 Activity on Microvascular Endothelial Cells

Chemokine Receptor N-Terminus Charge Dictates Reliance on Post-Translational Modifications for Effective Ligand Capture and Following Boosting by Defense Peptides

Cloning, Expression and Identification of an Isoform of Human Stromal Cell Derived Factor-1Α.